Fennec Pharmaceuticals Inc. (FENC)
NASDAQ: FENC · Real-Time Price · USD
6.70
-0.15 (-2.19%)
Apr 28, 2026, 4:00 PM EDT - Market closed

Fennec Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Net Income
-9.74-0.44-16.05-23.71-17.35
Upgrade
Other Amortization
0.070.160.290.150.02
Upgrade
Loss (Gain) From Sale of Investments
00.080.040.180.03
Upgrade
Stock-Based Compensation
7.035.065.354.224.01
Upgrade
Provision & Write-off of Bad Debts
2.214.6---
Upgrade
Other Operating Activities
2.80.57---
Upgrade
Change in Accounts Receivable
-12.44-7.87-7.27-1.55-
Upgrade
Change in Inventory
-1.280.58-1.58-0.58-
Upgrade
Change in Accounts Payable
1.39-0.541.391.61-0.79
Upgrade
Change in Unearned Revenue
-24.81---
Upgrade
Change in Other Net Operating Assets
-2.51-0.040.681.61-0.14
Upgrade
Operating Cash Flow
-12.4726.98-17.14-18.06-14.22
Upgrade
Long-Term Debt Issued
--525.175
Upgrade
Long-Term Debt Repaid
-19.48-13--5-0.01
Upgrade
Net Debt Issued (Repaid)
-19.48-13520.174.99
Upgrade
Issuance of Common Stock
44.241.31.720.930.03
Upgrade
Repurchase of Common Stock
-0.19-0.18-0.08-0.19-
Upgrade
Other Financing Activities
-1.95-1.74--0.18-0.04
Upgrade
Financing Cash Flow
22.63-13.626.6420.734.98
Upgrade
Net Cash Flow
10.1513.37-10.512.67-9.24
Upgrade
Cash Interest Paid
4.163.82---
Upgrade
Cash Income Tax Paid
0.75----
Upgrade
Levered Free Cash Flow
-7.33-0.29-12.35-9.17-7.73
Upgrade
Unlevered Free Cash Flow
-6.062.15-10.34-8.61-7.66
Upgrade
Change in Working Capital
-14.8316.94-6.781.1-0.93
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.